Briefly, A. aegypti CCL-125 cells were treated with Ubc9 inhibitor at a variety of concentrations either before, simultaneously, or after DENV2 infection at a multiplicity of infection (MOI) of 1. This evidence concerns the gene UBE2I and infection.